Cargando…
Case report: Adenosquamous carcinoma of the prostate with greater than 20 month response to multimodal therapy
Adenosquamous carcinoma is an extremely rare and lethal subtype of prostate cancer affecting an estimated 0.03 per million men annually. It has been associated with prior hormone therapy for prostate adenocarcinoma. We present a case of de novo adenosquamous carcinoma of the prostate treated with a...
Autores principales: | Hennessey, Alex, Buller, Dylan, Sama, Shashank, Girard, Eric, Clement, Jessica, Ristau, Benjamin T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906645/ https://www.ncbi.nlm.nih.gov/pubmed/31867218 http://dx.doi.org/10.1016/j.eucr.2019.101084 |
Ejemplares similares
-
Open versus minimally invasive surgery for suspected adrenocortical carcinoma
por: Buller, Dylan M., et al.
Publicado: (2021) -
Adenosquamous Carcinoma of the Cervix: A Population-Based Analysis
por: Cui, Pengfei, et al.
Publicado: (2021) -
Adenosquamous Carcinoma of the Breast: Case Report and Literature Review
por: Priyadarshini, Shista, et al.
Publicado: (2022) -
Adenosquamous Carcinoma of Skene’s Gland: A Case Report and Literature Review
por: Gao, Qian, et al.
Publicado: (2022) -
Comprehensive analyses of genomic features and mutational signatures in adenosquamous carcinoma of the lung
por: Wang, Hongbiao, et al.
Publicado: (2022)